Mortality Outcomes of Single-staged versus Multi-staged Complete Coronary Revascularization in Multivessel Non-ST Elevation Myocardial Infarction Patients

dc.contributor.authorYıldırım, Abdullah
dc.contributor.authorQuısı, Alaa
dc.contributor.authorAllahverdiyev, Samir
dc.contributor.authorGenç, Ömer
dc.contributor.authorHarbalıoğlu, Hazar
dc.contributor.authorAlıcı, Gökhan
dc.contributor.authorGür, Mustafa
dc.date.accessioned2023-07-26T11:50:42Z
dc.date.available2023-07-26T11:50:42Z
dc.date.issued2021
dc.departmentDÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Kardiyoloji Ana Bilim Dalıen_US
dc.description.abstractAim: The aim of this study was to compare the short-term and long-term mortality results of single-stage percutaneous coronary intervention (SS-PCI) and multi-stage percutaneous coronary intervention (MS-PCI) strategies in patients diagnosed with non-ST segment elevation myocardial infarction (NSTEMI) with multivessel disease. Material and Methods: A total of 298 consecutive patients diagnosed with multivessel NSTEMI (71 (23.8%) patients in the SS-PCI group and 227 (76.2%) patients in the MS-PCI group) were included in this study. Data regarding mortality were obtained from the health information system of our institute and national health registry. Results: Although in-hospital mortality rates were found to be significantly higher in univariate analysis in the SS-PCI group compared to the MS-PCI group (14.1% (n=10) vs 4.0% (n=9); p=0.005), it was not independently associated with total mortality in multiple model. Among the parameters predicted mortality determinants, low hemoglobin (odds ratio (OR)=0.485, 95% confidence interval (CI)=0.332-0.708; p=0.002), No-reflow occurrence (OR=6.194, 95% CI=1.310-29.300, p=0.021), not using post dilatation (OR=0.287, 95% CI=0.085-0.970, p=0.045) were independently associated with total mortality. Conclusion: There was no statistical difference in overall mortality between the two study groups in multivessel NSTEMI patients who underwent complete coronary revascularization with the SS-PCI and MS-PCI strategy, while low hemoglobin, No-reflow phenomenon, and not using post-dilatation were found as independent predictors of mortality.en_US
dc.identifier.doi10.18678/dtfd.868952
dc.identifier.endpage136en_US
dc.identifier.issn1307-671X
dc.identifier.issue2en_US
dc.identifier.startpage129en_US
dc.identifier.trdizinid498457en_US
dc.identifier.urihttp://doi.org/10.18678/dtfd.868952
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/498457
dc.identifier.urihttps://hdl.handle.net/20.500.12684/12409
dc.identifier.volume23en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.institutionauthorHarbalıoğlu, Hazar
dc.language.isoenen_US
dc.relation.ispartofDüzce Tıp Fakültesi Dergisi
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmz$2023V1Guncelleme$en_US
dc.subjectnon-culprit lesionen_US
dc.subjectnon-ST segment elevation myocardial infarctionen_US
dc.subjectMultivessel coronary artery diseaseen_US
dc.titleMortality Outcomes of Single-staged versus Multi-staged Complete Coronary Revascularization in Multivessel Non-ST Elevation Myocardial Infarction Patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12409.pdf
Boyut:
432.28 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text